Fact CheckerSign in

NCT06997575CompletedPhase 4

Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia

Frequency of Recurrence of Seizures With Intravenous Versus Intramuscular Magnesium Sulphate in Women With Eclampsia

Source: ClinicalTrials.gov · Last updated 15 Dec 2025

Brief summary (registry, in English)

The goal of this clinical study is to learn whether the way we give magnesium sulphate-into a vein (intravenous, IV) versus into a muscle (intramuscular, IM)-affects how often women with eclampsia have repeat seizures. The main question it aims to answer is: 1\. Do women who receive IV magnesium sulphate have fewer recurrent seizures than those who receive IM magnesium sulphate? Researchers will compare two groups of women with eclampsia: one group will receive a bolus and a continuous IV infusion of magnesium sulphate, and the other will receive a combined IV-plus-IM dosing regimen. Participants will: 1. Be women aged 18-45 years diagnosed with eclampsia in the labour room. 2. Have their basic health information (age, gestation, parity, body mass index) recorded 3. Be randomly assigned (by sealed envelope) to receive either the IV regimen (4 g loading dose then 1 g/hour infusion) or the IM regimen (10 g loading dose with 4 g IV plus 6 g IM, then 2.5 g IM every 4 hours). 4. Continue treatment for 24 hours after their last seizure or delivery, whichever is later. 5. Be monitored in hospital for seizure recurrence. 6. Have any repeat seizure treated immediately with an extra IV dose of magnesium sulphate.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
200 (actual)
First submitted
21 May 2025
Start date
13 May 2025
Primary completion date
12 Nov 2025
Lead sponsor
Nishtar Medical University
NCT number
NCT06997575

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 200
  • From 13 May 2025 to the primary completion date, 12 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Already received MgSO4, phenytoin and diazepam before attending the hospital

Other illness

  • Patients with intracranial bleeding (on CT-scan)

Who the study is looking for

  • Admitted in labor room due to eclampsia (new onset of grand mal seizure activity and/or unexplained coma during pregnancy)

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nishtar Medical University & Hospital
Coordinator of this site? Confirm its status
MultanPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.